Evidence map›Paper›PMID 40584413›Full record

ArticleNanophotonics (Berlin, Germany)2025

Absorption and amplification singularities in metasurface etalons with gain.

Nelson de Gaay Fortman, Georg-Michael Krause, Peter Schall, A Femius Koenderink

Abstract read
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nelson de Gaay FortmanInstitute of Physics, University of Amsterdam, 1098 XH, Amsterdam, The Netherlands.ORCID https://orcid.org/0009-0005-0338-5203
Georg-Michael KrauseDepartment of Physics of Information in Matter and Center for Nanophotonics, NWO-I Institute AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands.
Peter SchallInstitute of Physics, University of Amsterdam, 1098 XH, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-2612-2762
A Femius KoenderinkInstitute of Physics, University of Amsterdam, 1098 XH, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-1617-5748

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Passive reflective metasurfaces can possess perfect absorption conditions: Singular scattering anomalies at which all impinging light is absorbed. Perfect absorption is a common yet powerful metasurface design option with applications in energy harvesting, sensing, and more. Less common is the inclusion of optical gain to the system, which can give rise to a singular condition for perfect amplification. We analyze absorption and amplification singularities in plasmon antenna metasurface etalons with gain with a simple transfer matrix model. Our etalon follows the Salisbury screen design: A metal ground plate spaced by dielectric medium from an array of resonant plasmonic scatterers. We include frequency dispersive models for gain media and discuss the limitations of time reversal symmetry arguments for relating gain singularity conditions (reflectivity poles) to the well-known perfect absorption conditions (reflectivity zeros) of metasurface etalons. We show that for metasurface etalons with both gain and loss, gain can induce both perfect absorption and gain singularities, and we describe topological constraints on their creation and annihilation. Our findings have implications for the fields of non-Hermitian photonics, parity-time symmetric scattering systems, and dynamically controllable active metasurface pixels.

Indexed as

metasurfaceoptical gainsingular optical response

Identifiers

PMID40584413
PMCPMC12199557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.